Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
Open | $4.140 |
Close | - |
Volume / Avg. | 44.242K / 21.751K |
Day Range | 4.010 - 4.240 |
52 Wk Range | 3.510 - 44.800 |
Market Cap | $2.729M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 56.93% |
Days to Cover | 5.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Path Hldgs (NASDAQ: BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Synaptogenix (NASDAQ:SNPX), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Bio-Path Hldgs (NASDAQ: BPTH) was reported by Roth MKM on Wednesday, March 27, 2024. The analyst firm set a price target for 40.00 expecting BPTH to rise to within 12 months (a possible 890.10% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $4.04 last updated Today at March 28, 2024 at 8:00 AM EDT.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.